Fiji vs Namibia: Amphetamine use disorder death rate
Fiji
0.01 deaths per 100,000 people
in 2021
Namibia
0.01 deaths per 100,000 people
in 2021
Fiji rank
106th
Namibia rank
106th
Amphetamine use disorder death rate over time
- Fiji
- Namibia
How they compare
Fiji currently reports 0.01 deaths per 100,000 people against 0.01 deaths per 100,000 people in Namibia, a difference of 0 deaths per 100,000 people.
Across all 22 years both countries report, Namibia has been ahead every year.
Fiji ranks 106th and Namibia ranks 106th of 194 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Fiji | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.008 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0.002 deaths per 100,000 people | Namibia |
| 2010s | 0.007 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0.003 deaths per 100,000 people | Namibia |
| 2020s | 0.01 deaths per 100,000 people | 0.01 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder death rate, Fiji or Namibia?
- Fiji, at 0.01 deaths per 100,000 people against 0.01 deaths per 100,000 people in Namibia as of 2021.
- What is the difference in amphetamine use disorder death rate between Fiji and Namibia?
- 0 deaths per 100,000 people, with Fiji ahead.
- How many years of comparable data are there for Fiji and Namibia?
- 22 years are reported by both, from 2000 to 2021.
- How do Fiji and Namibia rank globally for amphetamine use disorder death rate?
- Fiji ranks 106th and Namibia ranks 106th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders in both sexes, per 100,000 people.